Home › Endometrial Cancer › NCT06365905

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Who can join

Ages 55 and older · Women

Inclusion Criteria:

* Age ≥ 55 years
* At least one episode of postmenopausal bleeding (PMB)
* Endometrial biopsy available from at Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System (MCHS), or an external institution
* Acceptance to participate in the study

Exclusion Criteria:

* Diagnostic tests performed more than 90 days apart
* Physical impediment/refusal to undergo transvaginal ultrasound (TVUS)

About the study

This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 300 · Started: Mar 27, 2024

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT06365905

Locations in the U.S.

Conditions

• Endometrial Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.